Financial crisis hits global merger and acquisition deals
October 26th, 2008 - 3:36 pm ICT by IANS ( Leave a comment )New Delhi, Oct 26 (IANS) Outbound merger and acquisition (M&A) deals have been hit by the global financial crisis, losing their valuation by 76 percent this year, according to an industry lobby study. The report, released by the Associated Chambers of Commerce and Industry of India (Assocham), said 72 M&As worth $3.73 billion took place in the April-August period this year as against 54 deals worth $15.5 billion in the same period last year.
Despite the global slowdown, altogether 18 outbound M&As took place in the IT sector, followed by 11 in pharmaceutical, nine in telecom and two in power.
In terms of valuation, the pharmaceutical sector topped the list at $5.25 billion with 38.69 percent of the total valuation of M&A deals. The telecom sector accounted for 17.41 percent, while the IT and power sectors accounted for 15 percent and 8.44 percent respectively.
The major inbound M&A deal in the pharmaceutical sector was Japan’s Daiichi Sankyo acquiring 51 percent stake of Indian pharma giant Ranbaxy Laboratories for $4.6 billion.
Other sectors such as metal and mining, auto, banking and finance, chemical, petrochemical, construction, engineering, healthcare, manufacturing, media, real estate and textile witnessed 75 M&A deals worth $3.64 billion, accounting for a 20.46 percent share.
- Mergers and acquisitions drop 41.5 percent in 9 months - Oct 07, 2011
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
- Inbound merger and acquisitions set to increase: Assocham - Apr 23, 2009
- Foreign takeover of Indian drug-makers leaves ministry worried - Aug 04, 2011
- Daiichi eyes Ranbaxy for expanding in Africa, Latin America - Mar 12, 2010
- Foreign investment in pharma to face competition check - Oct 11, 2011
- Competition check for FDI in pharma will help consumers: CUTS - Oct 11, 2011
- Telecom panel to meet again on mergers, license norms - Nov 28, 2011
- Ranbaxy, Russian region sign healthcare pact - Jan 31, 2011
- Ranbaxy to launch anti-diabetic drug Actos by 2012 - Mar 15, 2010
- Daiichi says Ranbaxy acquisition will hit its bottomline - Jan 05, 2009
- 'Indian investors saved 65,000 jobs in US' - Nov 03, 2010
- Ranbaxy concludes deal with Daiichi - Nov 07, 2008
- India invested $26.6 bn; created 60,000 jobs in US: Study - Jun 16, 2010
- Parkway stake makes Fortis largest Asian hospital chain - Mar 12, 2010
Tags: acquisition deals, chemical petrochemical, daiichi sankyo, global financial crisis, global merger, global slowdown, merger and acquisition, pharmaceutical sector, power sectors, ranbaxy laboratories